IP Library Granted Patent US 7,088,914
Granted Patent B2
US 7,088,914 · App. 10/494,136 · Granted Aug 8, 2006

Device, method and resistive element for vaporizing a medicament

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,088,914
App. No.
10/494,136
Granted
Aug 8, 2006
Kind
B2
Abstract

A device for vaporizing a medicament ( 4 ). The device comprises a resistive element ( 9 ) on which the medicament is deposited. The device also comprises a source of electrical power which can be connected across the resistive element to vaporize the medicament. The element is configured to provide a central cool region ( 11 ) on which the medicament is deposited and a relatively hotter region ( 12 ) surrounding the cool region. Through holes ( 13 ) are also provided. The resistive element may be a mesh, foil or a tile on which a resistive pattern is deposited.

Claims (10)

1. A method for vaporising a substance positioned in thermal communication with a resistive element, the method comprising connecting the resistive element to an electrical power supply and controlling the supply of electrical power to the resistive element to vaporize the substance by varying the duty cycle of the power supply to ensure that the resistive element reaches a target temperature, and then reducing the duty cycle to maintain the target temperature for sufficient time to vaporise the substance, and wherein the resistive element is configured to produce, in use, a relatively cool central region and a relatively hot region at least partially surrounding the cool region.

2. A method according to claim 1 , further comprising controlling the power to vaporise the substance without pyrolysis.

3. A method according to claim 1 , wherein there are a plurality of resistive elements, the method further comprising selectively vaporizing the substance on the resistive elements in turn.

4. A method according to claim 3 , wherein the selectively vaporising step comprises progressively moving at least one of the resistive elements into a vaporising position and connecting the electrical power supply to the resistive element in the vaporising position.

5. A method according to claim 1 , further comprising measuring the resistance once the resistive element is connected to the electrical power supply and adjusting the duty cycle of the power supply to compensate for variations in the measured resistance.

6. A method according to claim 1 , wherein the substance is vaporised in one inspiratory cycle.

7. A method according to claim 1 , wherein the substance is vaporised in a number of inspiratory cycles.

8. A method according to claim 1 , wherein the target temperature is selected such that only constituents in the substance which have a relatively low boiling point are vaporized.

9. A method according to claim 1 , wherein the resistive element is a foil.

10. A method according to claim 1 , wherein the resistive element is a mesh which is sized so that, in use, the thermal mass of the medicament is sufficient to produce the relatively cool central region.

Assignments (1)
SECURITY AGREEMENT Recorded Jul 22, 2021
From: GW PHARMA LIMITED; GW RESEARCH LIMITED
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056958/0493 →